EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
REGENXBIO Inc.
RGNX

RGNX REGENXBIO Inc.

REGENXBIO Inc. · NASDAQ
Market Closed
8.53
▼ ⁦-0.35%⁩ (-0.03)
Market Cap$441.0M
Beta0.94
52w Low52w High
5.4616.19
Last Week
⁦-7.28%⁩
Last Month
⁦-18.14%⁩
Last 3 Months
⁦+27.50%⁩
Last Year
⁦-6.47%⁩
EL7 Factor Analysis
How we score this
Overall13
Poor — bottom quartile of the marketSucker StockF 4/9DistressBetter than 13% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
19
—17.8xBottom tier
▸
Growth
79
12.0%▲7.1%Top tier
▸
Quality
31
-76.0%▼4.5%Bottom tier
▸
Safety
17
—2.6xBottom tier
▸
Capital Return
80
—2.12%Top tier
▸
Momentum
37
20.0%▲2.9%Bottom tier
▸
Sentiment
84
7▲3Top tier

Frequently Asked Questions

What is REGENXBIO Inc. stock?▼

REGENXBIO Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.

How can I invest in REGENXBIO Inc.?▼

You can buy REGENXBIO Inc. shares through a licensed brokerage. Research the company's financials before investing.

What are the key metrics for evaluating REGENXBIO Inc.?▼

Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.

Does REGENXBIO Inc. pay dividends?▼

Dividend policies vary by company. Check the dividends section on the stock page for the payout history.

What are the risks of investing in REGENXBIO Inc.?▼

Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.

Fair Value
Low confidenceCurrent price$8.53
Analyst target · 3 analysts
$18
—
Range ⁦$12–$29⁩
vs
DCF (estimate)
N/A (negative FCF)

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener

AI analysis from the earnings call, financials and news

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 3 analysts setting price target
$19.60
⁦+129.8%⁩
Current Price $8.53·Median $18.00
Low
$12.00
High
$29.00
Current price
$8.53
Average target
$19.60
Street summary

Adjustment of price targets for REGENXBIO (RGNX) stock

The consensus price target for RGNX stock saw a decline of 4.85% over the last week, falling from $20.6 to $19.6, despite remaining 2.4% higher compared to levels from 30 days ago. This recent adjustment reflects a state of caution, especially with a sharp Analyst Dispersion ranging between $12 and $29, indicating high uncertainty regarding future valuation despite the stock currently trading at $8.91, a level even lower than the lowest price target.

As of 2026-08-25
Revisions momentum · 30d
⁦-4.8%⁩
Average rating
★ 4.09
Buy
Analyst coverage
11
Buy conviction
82%
High
Target dispersion
199%
Wide
Analyst ratings over time11 analysts rating
3
6
2
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months4.27 → 4.09
Recent analyst moves
  • = Reiterate2026-08-10
    H.C. Wainwright
    Buy
  • ⬇ Downgrade2026-08-07
    Barclays
    OverweightPositive
  • = Reiterate2026-08-07
    Morgan Stanley
    Overweight
Premium content
Financial Analysis
|